These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1967448)

  • 21. Derlin-1-immunopositive inclusions in patients with Alzheimer's disease.
    Honjo Y; Ito H; Horibe T; Shimada H; Nakanishi A; Mori H; Takahashi R; Kawakami K
    Neuroreport; 2012 Jul; 23(10):611-5. PubMed ID: 22627700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.
    Smith MA; Kutty RK; Richey PL; Yan SD; Stern D; Chader GJ; Wiggert B; Petersen RB; Perry G
    Am J Pathol; 1994 Jul; 145(1):42-7. PubMed ID: 8030754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons.
    Yamamoto T; Hirano A
    Ann Neurol; 1985 Jun; 17(6):573-7. PubMed ID: 4026228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease.
    Mesulam MM; Asuncion Morán M
    Ann Neurol; 1987 Aug; 22(2):223-8. PubMed ID: 3662453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothalamic pathology in Alzheimer's disease.
    Saper CB; German DC
    Neurosci Lett; 1987 Mar; 74(3):364-70. PubMed ID: 2436113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease.
    Esiri MM; Pearson RC; Steele JE; Bowen DM; Powell TP
    J Neurol Neurosurg Psychiatry; 1990 Feb; 53(2):161-5. PubMed ID: 2313304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.
    Hansen L; Salmon D; Galasko D; Masliah E; Katzman R; DeTeresa R; Thal L; Pay MM; Hofstetter R; Klauber M
    Neurology; 1990 Jan; 40(1):1-8. PubMed ID: 2153271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathology of the cytoskeleton in Alzheimer's disease and disorders related to this disease].
    Seitelberg F; Lassmann H
    Gac Med Mex; 1990; 126(5):367-73. PubMed ID: 1966495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perforant pathway changes and the memory impairment of Alzheimer's disease.
    Hyman BT; Van Hoesen GW; Kromer LJ; Damasio AR
    Ann Neurol; 1986 Oct; 20(4):472-81. PubMed ID: 3789663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antemortem diagnosis of diffuse Lewy body disease.
    Crystal HA; Dickson DW; Lizardi JE; Davies P; Wolfson LI
    Neurology; 1990 Oct; 40(10):1523-8. PubMed ID: 2170865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Lewy bodies in Alzheimer's disease.
    Gibb WR; Lees AJ
    Ann Neurol; 1989 Nov; 26(5):691-3. PubMed ID: 2554794
    [No Abstract]   [Full Text] [Related]  

  • 32. [Importance of neurofibrillary degeneration in the diagnosis of Alzheimer's disease].
    Gómez-Ramos P; Jiménez A; Cebrián JL; Morán MA
    Med Clin (Barc); 1993 Jun; 101(2):60-3. PubMed ID: 8510479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cortex of the primary auditory area in Alzheimer's disease.
    Esiri MM; Pearson RC; Powell TP
    Brain Res; 1986 Feb; 366(1-2):385-7. PubMed ID: 3697692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD.
    Dickson DW; Ruan D; Crystal H; Mark MH; Davies P; Kress Y; Yen SH
    Neurology; 1991 Sep; 41(9):1402-9. PubMed ID: 1653914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortical changes in the parkinsonian brain: a contribution to the delineation of "diffuse Lewy body disease".
    Yoshimura M
    J Neurol; 1983; 229(1):17-32. PubMed ID: 6189974
    [No Abstract]   [Full Text] [Related]  

  • 36. [Neurofibrillary changes and phosphorylated tau of Alzheimer's disease].
    Takeda M; Kudo T; Taniguchi N; Nishimura T
    Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):169-72. PubMed ID: 8648891
    [No Abstract]   [Full Text] [Related]  

  • 37. Dementia and Parkinson's disease--pathological and neurochemical considerations.
    Quinn NP; Rossor MN; Marsden CD
    Br Med Bull; 1986 Jan; 42(1):86-90. PubMed ID: 3006860
    [No Abstract]   [Full Text] [Related]  

  • 38. Alzheimer's disease: does neuron plasticity predispose to axonal neurofibrillary degeneration?
    Ashford JW; Jarvik L
    N Engl J Med; 1985 Aug; 313(6):388-9. PubMed ID: 4010760
    [No Abstract]   [Full Text] [Related]  

  • 39. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
    Joachim CL; Morris JH; Kosik KS; Selkoe DJ
    Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and partial characterization of neurofibrillary tangles and amyloid plaque core in Alzheimer's disease: immunohistological studies.
    Gorevic PD; Goñi F; Pons-Estel B; Alvarez F; Peress NS; Frangione B
    J Neuropathol Exp Neurol; 1986 Nov; 45(6):647-64. PubMed ID: 3772397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.